^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    KY100001

    i
    Other names: KY100001
    Associations

    News

    Trials
    Company:
    KPC Pharma
    Drug class:
    IDH1 inhibitor
    Related drugs:
    Associations

    News

    Trials
    almost3years
    Safety,Tolerability, Pharmacokinetic,Pharmacodynamics and Efficacy of KY100001 in Patients With Advanced Solid Tumors (clinicaltrials.gov)
    P1, N=109, Not yet recruiting, Kunming Pharmaceuticals, Inc.
    Clinical • New P1 trial
    |
    IDH1 (Isocitrate dehydrogenase (NADP(+)) 1)
    |
    IDH1 mutation
    |
    KY100001